Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1 192 or PON1 55 Genotype
- 1 November 2000
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (11), 2441-2447
- https://doi.org/10.1161/01.atv.20.11.2441
Abstract
—The paraoxonase (PON1) PON1-Q192R and PON1-L55M polymorphisms have been inconsistently associated with vascular disease. Plasma PON1 activity phenotypes vary markedly within genotypes and were, therefore, expected to add to the informativeness of genotype for predicting vascular disease. The case-control sample included 212 age- and race-matched men (mean age 66.4 years). The 106 carotid artery disease (CAAD) cases had >80% carotid stenosis, and the 106 controls had P =0.005; DZOase, P =0.019). DZOase predicted vascular disease independently of lipoprotein profile, high density lipoprotein subfractions, apolipoprotein A-I, and smoking. PON1-192 and PON1-55 genotypes or haplotypes did not predict case-control status unless the activity phenotype was also included as a predictor by use of logistic regression. When phenotype was included as a predictor, PON1-192 and PON1-55 genotypes or combined haplotypes were significant predictors ( P PON1-192 and/or PON1-55 genotypes alone may mistakenly lead to the conclusion that there is no role of PON1 in CAAD. These results support the benefit of a “level crossing” approach that includes intervening phenotypes in the study of complexly inherited disease.Keywords
This publication has 27 references indexed in Scilit:
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.JCI Insight, 1997
- Paraoxonase gene polymorphism in Japanese subjects with coronary heart diseaseInternational Journal of Cardiology, 1996
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM StudyAtherosclerosis, 1996
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.JCI Insight, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxificationChemico-Biological Interactions, 1993
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Genetic polymorphism and interethnic variability of plasma paroxonase activity.Journal of Medical Genetics, 1976